Search

everythinglearnresearchcommunity

for

Search:↓

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Drugs like PDEI may help hair disorders like AGA.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.

Cyclosporine A may help treat hair loss by blocking a protein that inhibits hair growth.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Finasteride improves hair growth in men with androgenetic alopecia.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Finasteride and dutasteride effectively treat hair loss, but may cause side effects like sexual dysfunction and depression.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Long-term use of a certain medication can worsen erectile function in aged rats by damaging penile muscle cells.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Chitosan-coated nanoparticles improve skin delivery of hair loss treatments with fewer side effects.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.